Search Results for agency_names:"National Institutes of Health"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 12, 2025. This meeting is to evaluate grant applications and will take place via video conference. It is closed to the public to protect confidential information and personal privacy. For more details, Mairi Noverr can be contacted at the National Institutes of Health.

The National Institute on Aging is holding a closed meeting on January 10, 2025, to review and evaluate grant applications related to bone regulation. The meeting will be conducted virtually from 10:00 a.m. to 5:00 p.m. The session is closed to the public because it will involve discussions of confidential information, like trade secrets or personal details in grant applications, which must remain private. Dr. Nijaguna Prasad is the contact person for the meeting, and inquiries can be directed to him via phone or email.

The National Institute of Allergy and Infectious Diseases (NIAID) will hold a special meeting on February 23, 2021, to review and evaluate grant applications. This meeting will be conducted virtually and is closed to the public to protect confidential information related to trade secrets and personal privacy. Zhuqing (Charlie) Li, Ph.D., will serve as the Scientific Review Officer for this session. The meeting agenda will focus solely on research projects that do not involve clinical trials.

The National Institutes of Health (NIH) Office of the Director has announced a virtual meeting of the Scientific Management Review Board scheduled for January 10, 2025, from 11:00 a.m. to 1:00 p.m. The meeting is open to the public, and individuals can pre-register to attend. The agenda includes setting priorities and reviewing past recommendations and reports. People interested in submitting written comments can contact Dr. Tyrone Spady, whose details are provided in the notice.

The document is a notice from the National Institutes of Health announcing several closed meetings organized by the Center for Scientific Review. These meetings are set to occur between March 16 and March 18, 2021, and are focused on evaluating various grant applications related to different scientific fields. The agenda for each meeting is to review and assess these applications, and the closed status is to prevent disclosure of sensitive information such as patentable materials and private personal details. The notice includes details about the committees involved, the dates, times, and how to contact the corresponding Scientific Review Officers.

The National Institutes of Health (NIH), part of the Department of Health and Human Services, is seeking public comments as part of their routine process under the Paperwork Reduction Act of 1995. They aim to gather qualitative feedback on agency service delivery to improve performance. This initiative is not intended to generate statistical data but to gather insights and opinions that help enhance the quality of NIH's services. Stakeholders or customers who have interacted with NIH services are encouraged to provide their feedback within 60 days of the notice's publication date.

The National Institute of Allergy and Infectious Diseases (NIAID) is holding a closed meeting of the Special Emphasis Panel on May 13-14, 2025. This meeting will review and evaluate grant applications for the Engineering Durable HIV Vaccine Protection (ENDURE) initiative. It will be held virtually at the NIH's facilities in Rockville, MD. The meeting is closed to the public to protect confidential trade secrets, commercial property, and personal information associated with the grant applications.

The National Institutes of Health announced a closed meeting of the National Advisory Council for Biomedical Imaging and Bioengineering scheduled for June 4, 2025. This meeting will be closed to the public due to discussions that may reveal confidential trade secrets or personal information. It will be held virtually and focus on reviewing and evaluating grant applications. For more information or to submit comments, individuals can contact Anna Taylor, Ph.D., at the details provided in the announcement.

The National Institutes of Health (NIH) announced several upcoming closed meetings of the Center for Scientific Review Special Emphasis Panels. These meetings, occurring in early March 2021, will review and assess grant applications in various scientific fields, including genetics, cell biology, neuroscience, and more. The meetings are closed to protect confidential information and privacy, as required by law. Contact details for the relevant NIH officers are provided for each meeting.

The National Cancer Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to Kyverna Therapeutics for technology involving chimeric antigen receptors (CARs) that target the CD19 protein. This technology is aimed at creating a treatment for autoimmune diseases using a patient’s own altered T lymphocytes. The license could cover worldwide territories and would allow Kyverna to develop, produce, and market this therapy. Public comments or objections about the patent license need to be submitted by March 5, 2021.